Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Wilmington, Delaware
- Most recent report
- 8-K, filed Sep 16, 2026
- Incorporated
- Delaware
- Filings on record
- 472 filings
- On EDGAR
- CIK 1719406
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 43
News 8 of 134
Prospectuses and Registrations 8 of 86
- 424B5 Prospectus supplement for an offering Jun 3, 2026
- 424B5 Prospectus supplement for an offering Jun 2, 2026
- 25-NSE Notice that a security was delisted May 22, 2026
- 424B5 Prospectus supplement for an offering Feb 17, 2026
- 424B3 Prospectus supplement for an offering Dec 22, 2025
- S-3/A Shelf registration statement, amended Dec 12, 2025
- 424B5 Prospectus supplement for an offering Aug 18, 2025
- S-3 Shelf registration statement Jun 20, 2025
Proxies 8 of 31
- DEFA14A Extra proxy material Feb 24, 2026
- DEF 14A Proxy statement for a shareholder vote Feb 23, 2026
- PRE 14A Preliminary proxy statement Feb 13, 2026
- DEF 14A Proxy statement for a shareholder vote Sep 5, 2024
- PRE 14A Preliminary proxy statement Aug 27, 2024
- DEFA14A Extra proxy material Mar 20, 2024
- DEFA14A Extra proxy material Mar 18, 2024
- DEFA14A Extra proxy material Mar 13, 2024
Ownership 8 of 114
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 15, 2026
- 4 Insider reported a trade Feb 17, 2026
- 3 Insider reported their initial holding Feb 17, 2026
- 4 Insider reported a trade Sep 10, 2025
- 4 Insider reported a trade Sep 10, 2025
- 4 Insider reported a trade Sep 10, 2025
- 4 Insider reported a trade Sep 10, 2025
- SCHEDULE 13G Large holder reported a passive stake Aug 21, 2025
Other 8 of 64
- ARS Annual report sent to shareholders Feb 23, 2026
- EFFECT Notice that a registration became effective Dec 22, 2025
- CORRESP Reply to SEC staff Dec 18, 2025
- NT 10-Q Notice that a quarterly report will be late Aug 14, 2025
- RW Jun 24, 2025
- UPLOAD Comment letter from SEC staff Jun 24, 2025
- D Mar 7, 2025
- ARS Annual report sent to shareholders Nov 22, 2023
Everything here comes from NRX Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.